← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 124개
ADCBiologicstaleMultitude Therapeutics Inc.Phase 2

AMT-116 (AMT-116)

Advanced Non-small Cell Lung Cancer (NSCLC) · Advanced Non-small Cell Lung Cancer (NSC

#AdvancedNon-smallCellLungCancerN#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
AntibodystalePeregrine PharmaceuticalsPhase 2

bavituximab (bavituximab)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 9%임상시험 4상태 ACTIVE
ADCBiologicstaleGenentech, Inc.Phase 2

DNIB0600A (DNIB0600A)

Non-Squamous Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer, Ovarian Canc

#Non-SmallCellLungCancerOvarianCa#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 ACTIVE
ADCBiologicstaleAstraZenecaPhase 2

AZD0171 (AZD0171)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 34.9%임상시험 2상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 2

BNT326 (BNT326)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
AntibodystaleAbbViePhase 1

Cofetuzumab Pelidotin (Cofetuzumab Pelidotin)

Cancer; Non-small Cell Lung Cancer (NSCLC) · Cancer

#Cancer#Antibody#Phase1#항체#면역항체+3
임상시험 2상태 DISCONTINUED
ADCBiologicstaleEnliven TherapeuticsPhase 1

ELVN-002 (ELVN-002)

HER2 Mutant Non-small Cell Lung Cancer; HER2-positive Metastatic Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
AntibodystaleEli Lilly and CompanyPhase 2

cixutumumab (IMC-A12, IMC-A12 (cixutumumab))

Non-Small Cell Lung Cancer · Colon Cancer

#ColonCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 37.9%임상시험 2상태 ACTIVE
ADCBiologicstalePfizerPhase 3

PF-08046054 (PF-08046054)

Non-small Cell Carcinoma; Non-Small Cell Lung Cancer Metastatic · Non-small Cell Carcinoma

#Non-smallCellCarcinoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 1

SEA-TGT (SEA-TGT)

Non-small Cell Lung Cancer; Gastric Carcinoma · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 33.3%임상시험 2상태 DISCONTINUED
CGTBiologicstaleInge Marie SvanePhase 2

Young TIL (Young TIL)

Metastatic Colorectal Cancer; Metastatic Pancreatic Cancer · Advanced Non-Small Cell Lung Cancer

#AdvancedNon-SmallCellLungCancer#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 33.3%임상시험 2상태 RECRUITING
ADCBiologicstaleAbbViePhase 1

ABBV-221 (ABBV-221)

Head and Neck Squamous Cell Carcinoma; Non-small Cell Lung Cancer · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleBioNTech SEPhase 1

ALK-inhibitor or RET-inhibitor (ALK-inhibitor or RET-inhibitor)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleALX Oncology Inc.Phase 1

ALX2004 (ALX2004)

NSCLC (Advanced Non-small Cell Lung Cancer); HNSCC · NSCLC (Advanced Non-small Cell Lung Canc

#NSCLCAdvancedNon-smallCellLungCa#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleJeffrey ClarkePhase 1

AMG 479, Everolimus, Panitumumab (AMG 479, Everolimus, Panitumumab)

Advanced Solid Tumors, Non-small Cell Lung Cancer · Advanced Solid Tumors, Non-small Cell Lu

#AdvancedSolidTumorsNon-smallCell#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 ACTIVE
CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 2

AMT-116 CAR-T cells (AMT-116 CAR-T cells)

Melanoma; Non-small Cell Lung Cancer · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 2

AMT-253 CAR-T cells (AMT-253 CAR-T cells)

Melanoma; Non-small Cell Lung Cancer · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleThe Catholic University of KoreaPhase 2

Ex vivo-expanded NK cell enriched lymphocytes (ANKL, ANKL(Ex vivo-expanded NK cell enriched lymphocytes))

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleSidney Kimmel Comprehensive Can…Phase 2

nivolumab (Opdivo, Adagrasib/Nivolumab)

Resectable Non-Small Cell Lung Cancer · Resectable Non-Small Cell Lung Cancer

#ResectableNon-SmallCellLungCance#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 2

Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel (Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

3 / 7 페이지

← 이전다음 →